-
The annual average fine particle concentration at 0.1° ×0.1° spatial resolution was obtained from the 'Ambient air pollution exposure estimation for the Global Burden of Disease 2013' dataset[8]. The globally annual average PM2.5 at 0.1° ×0.1° spatial resolution in this dataset was estimated by combining satellite-based estimates, chemical transport model simulations, and ground measurements from 79 different countries[8]. We extracted the concentration of PM2.5 at 0.1° ×0.1° spatial resolution in Guangzhou city by matching the latitude and longitude from the dataset. The population-weighted PM2.5 exposure concentration was calculated based on the population density at 0.1° ×0.1° spatial resolution original from 'Gridded Population of the World, version 3, GPWv3'[23] in the same dataset. To explore the trend of PM2.5 concentration in Guangzhou, the annual population-weighted average concentrations for five-year intervals from 1990 to 2010 and the years of 2011 and 2012 were also calculated based on the same dataset through the process displayed above.
-
Information of the sex-and age-specific lung cancer mortality and incidence, and population data were derived from the Annual Report of Guangzhou Cancer Registry. In China, cancer surveillance is a routine work of each local Center for Disease Control and Prevention (CDC) guided by the national CDC. The cancer surveillance program was started in 2004 in Guangzhou with elaborate design and quality control procedures. As the surveillance program covers all districts in Guangzhou, surveillance data from this program are likely city-wide representative and credible. Based on the surveillance data, we calculated the disability-adjusted life years (DALYs) using the same method in the Global Burden of Disease (GBD)[24-25]. The details of the calculation are provided below.
First, we estimated the years of life lost (YLL) using the following Equation 1:
$$YLL = \sum {d_x} \times L$$ (1) x is the onset age of death, dx is the number of deaths at age x, L is the life expectancy at age x. In the current study, the standard life table employed was the same as that of the GBD study, which was based on the lowest observed death rate for each age group in countries with a population of more than 5 million[25]. Second, the years lived with disability (YLD) were estimated based on the Equation 2, as follows:
$$YLD = I \times DW \times L$$ (2) I is the incidence of disease within a certain period, DW is disability weight implying the severity of a certain disease status which was derived from the GBD disability weight study[26], and L is the average duration of a certain disease estimated by the DisMod-Ⅱ, a computer program developed specifically for the GBD study[27]. Therefore, we used incidence, mortality, remission rate (for lung cancer, we assumed the remission rate was zero) as inputs to get L for each age group. Finally, we estimated the DALY using the following Equation 3:
$$DALY = YLL + YLD$$ (3) -
Comparative risk analysis (CRA) was used to estimate the attributed disease burden of lung cancer due to PM2.5[28]. CRA is defined as the systematic evaluation of the changes in population health that result from modifying the population distribution of exposure to a risk factor towards counterfactual exposure rather than the difference between 'exposed' and 'unexposed' status[28]. The key of this method is to estimate the population attributable fraction (PAF), which indicates the proportion of disease burden attributed to a specific risk. The formula for calculating PAF in our study was the following Equation 4:
$$PAF = \frac{{\sum\limits_{i = 1}^n {{P_i}(R{R_i}} - 1)}}{{\sum\limits_{i = 1}^n {{P_i}(R{R_i} - 1) + 1} }}$$ (4) Pi is the fraction of population in exposure level i, RRiis the relative risk for exposure level i[29]. In our study, all populations were assumed to be exposed to the population-weighted average PM2.5 concentration estimated through the procedure displayed above because the individual exposure level data cannot be obtained. To use the same methods as the GBD studies, we adopted the feasible minimum risk distribution as counterfactual exposure because there was no consensus for a theoretical minimum exposure level, which is a uniform distribution between 5.8 μg/m3 and 8.8 μg/m3[30]. The RR of exposure to the factual level of PM2.5 compared with the counterfactual exposure was derived from the integrated exposure-response (IER) function introduced by Richard T Burnett[30]. The IER function was shown as following Equation 5, where z is the factual exposure level and zcf is the counterfactual exposure level. α, γ, and δ are parameters. For very large z, RR approximates 1 + α. δ is included to predict risk over a very large range of concentrations. γ can be interpreted as the ratio of the RR at low-to-high exposures[30].
$$\begin{array}{*{20}{l}} {Z < {Z_{cf}}}\\ {RR\left( z \right) = 1}\\ {Z \ge {Z_{cf}}}\\ {RR\left( z \right) = 1 + \alpha \left\{ {1 - {\rm{exp}}\left[ { - \gamma {{\left( {Z - {Z_{cf}}} \right)}^\delta }} \right]} \right\}} \end{array}$$ (5) The lung cancer burden attributed to PM2.5 pollution was calculated using DALYs of lung cancer multiply by PAF. Monte Carlo simulation-modelling techniques were used to estimate uncertainty ranges around point estimates reflecting the main sources of uncertainty in the calculations[25]. Suggested disease diagnostic uncertainty and coding uncertainty for each age, sex and year were considered when calculating YLL and YLD, in which ±7 percent uncertainty for non-communicable diseases was suggested by the GBD study[31]. In addition, the uncertainty of disability weight[26] was aggregated for YLD estimation, and the uncertainty from RR[30] was taken into the calculation of attributed burden of PM2.5. Uncertainty of YLL, YLD, and DALY has been captured by taking 1, 000 draws for each uncertainty of corresponding inputs. The 95% uncertainty interval (UI) around each quantity of interest is presented as the 2.5th and 97.5th centile values[25].
This study was based on official cancer surveillance aggregate data in Guangzhou, which did not contain any identifiable information. Analyses were conducted at the aggregate level and no confidential information was involved. The study was conducted in accordance with the Declaration of Helsinki.
-
Table 1 and Table 2 show the age-, and sex-specific incidence rate and mortality rate of lung cancer reported by the Annual Report of Guangzhou Cancer Registry in 2005 and 2013. The incidence rate of lung cancer in 2005 was 52.07 per 100, 000 (66.26 per 100, 000 for males and 37.14 per 100, 000 for females), which increased to 52.54 per 100, 000 (68.29 per 100, 000 for males and 36.49 per 100, 000 for females) in 2013. In addition, the mortality rate of lung cancer increased more sharply than the incidence rate, from 33.03 per 100, 000 (43.38 per 100, 000 for males and 58.88 per 100, 000 for females) to 43.47 per 100, 000 (22.18 per 100, 000 for males and 27.76 per 100, 000 for females) from 2005 to 2013. Both the incidence and mortality rates were increased consistently with the increase of age. Moreover, the incidence and mortality rates among males for each age group were approximately double compared to those among females.
Table 1. Age-, Sex-specific Incidence Rate (Per 100, 000) of Lung Cancer in 2005 and 2013 in Guangzhou, China
Age 2005 2013 Total Male Female Total Male Female 0- 0.28 0.10 0.47 0.06 0.11 0.00 20- 0.56 0.46 0.67 0.69 0.81 0.57 30- 1.11 1.46 0.75 4.11 3.48 4.72 40- 3.69 4.38 2.94 21.16 27.11 15.17 50- 10.93 13.92 7.93 72.83 95.31 49.77 60- 38.04 48.88 27.24 168.58 237.51 102.91 70- 104.06 148.63 64.94 303.94 433.71 189.10 80- 506.97 902.19 281.52 349.95 512.74 237.83 Total 52.07 66.26 37.14 52.54 68.29 36.49 Table 2. Age-, Sex-specific Mortality Rate (Per 100, 000) of Lung Cancer in 2005 and 2013 in Guangzhou, China
Age 2005 2013 Total Male Female Total Male Female 0- 0.00 0.00 0.00 0.06 0.11 0.00 20- 0.20 0.30 0.08 0.41 0.40 0.42 30- 0.53 0.98 0.08 2.32 2.27 2.36 40- 2.40 2.23 2.59 15.04 19.65 10.40 50- 6.27 7.91 4.64 54.34 78.27 29.79 60- 24.99 35.13 14.88 121.61 181.93 64.15 70- 66.16 103.06 33.78 268.43 401.98 150.25 80- 339.46 645.54 164.85 373.03 536.99 260.10 Total 33.03 43.38 22.18 43.47 58.88 27.76 -
Table 3 shows the lung cancer burden from 2005 to 2013 indicated by YLL, YLD, and DALY. There were increasing trends of DALY among both males and females. The DALYs for both males and females were higher in 2013 (48930.6 and 22522.9, respectively) than 2005 (35451.0 and 17004.0, respectively). The total DALYs have increased by 34.6% from 2005 to 2013. The increasing trends of YLL in males and females were similar with DALYs. While total YLD from 2005 to 2013 did not change apparently, YLD decreased slightly among males and slightly increased among females. To eliminate the impact of population increase, the rates of the three measurements were calculated. The DALY rates among both males and females also appeared to be raised, and the total DALY rate increased from 7.08 per 1, 000 to 8.61 per 1, 000. The number of DALYs among males was approximately double compared to that among females (Table 3) in both years. This pattern was similar for lung cancer incidence and mortality rates in males and females (Table 1 and Table 2). Figure 1 shows that, from 2005 to 2013, the disease burden increased consistently in each age group except the 30-age group and sharply increased after age 45 in both years. The age-standardized DALY rates of lung cancer were 6.27 per 1, 000 and 6.52 per 1, 000 in 2005 and 2013 respectively.
Table 3. Years of Life Lost (YLL), Years Lived with Disability (YLD), Disability-adjusted Life Years (DALYs) and the Corresponding Rates (per 1, 000) with 95% Uncertainty Interval for Lung Cancer in 2005 and 2013 in Guangzhou, China
Item 2005 2013 Total Male Female Total Male Female YLL 47527.0
(46491.7, 48507.1)32456.0
(31560.6, 33282.8)15071.0
(14670.7, 15474.9)66486.1
(65057.2, 67892.8)46540.8
(45272.9, 47791.3)19945.4
(19419.2, 204458)YLD 4928.0
(3939.6, 5975.1)2995.0
(2229.1, 3847.3)1933.0
(1424.9, 2453.4)4967.4
(4020.3, 6048.5)2389.8
(1779.4, 3069.1)2577.6
(1920.3, 3309.4)DALY 52455.0
(50888.4, 54047.3)35451.0
(34004.2, 36919.3)17004.0
(16191.1, 17799.1)71453.5
(69679.2, 73226.3)48930.6
(47289.5, 50533.3)22522.9
(21470.6, 23557.8)YLL
Rate6.42
(6.28, 6.55)8.60
(8.32, 8.78)4.20
(4.06, 4.28)8.01
(7.84, 8.18)11.11
(10.81, 11.41)4.85
(4.72, 4.97)YLD
Rate0.67
(0.53, 0.81)0.80
(0.59, 1.01)0.50
(0.39, 0.68)0.60
(0.48, 0.73)0.57
(0.42, 0.73)0.63
(0.47, 0.81)DALY
Rate7.08
(6.87, 7.30)9.40
(8.97, 9.74)4.70
(4.48, 4.92)8.61
(8.40, 8.82)11.68
(11.29, 12.07)5.48
(5.22, 5.73) -
The annual population-weighted average PM2.5 concentrations from 1990 to 2013 with five-year intervals are shown in Figure 2. The population-weighted average concentration of PM2.5 increased from 38.37 μg/m3in 1990 to 51.31 μg/m3 in 2013, indicating an increase of 34.6%. The PM2.5 concentration increased monotonously during the past decades, with a sharp rise between 2000 and 2005. While the increasing trend has declined during the recent years, the PAF increased consistently from 18.7% in 1990 to 23.1% in 2013. The average estimated PAF from 1990 to 2013 was 21.8% (from 18.7% to 23.1%), indicating that 21.8% of the total disease burden due to lung cancer was attributable to the PM2.5 pollution.
-
Table 4 shows that the attributed DALYs for both males and females increased from 2005 to 2013. The attributed DALYs were 12105.0 (8181.0 for males and 3924.0 for females) in 2005 and 16489.3 (11291.7 for males and 5197.6 for females) in 2011. Meanwhile, the same pattern was observed when we used the DALY rate, which was increased from 1.63 per 1, 000 (2.17 per 1, 000 for males and 1.08 per 1, 000 for females) in 2005 to 1.99 per 1, 000 (2.70 per 1, 000 for males and 1.26 per 1, 000 for females) in 2013. The standardized DALY rates of lung cancer were 1.45 per 1, 000 and 1.50 per 1, 000 in 2005 and 2013 respectively.
Table 4. Years of Life Lost (YLL), Years Lived With Disability (YLD), and Disability-adjusted Life Years (DALYs) with 95% Uncertainty Intervals for Lung Cancer Attributed to PM2.5 in 2013 in Guangzhou, China
Item 2005 2013 Total Male Female Total Male Female YLL 10967.8
(7229.5, 13964.7)7489.8
(4910.3, 9519.8)3477.9
(2282.6, 4425.9)15342.9
(10116.6, 19542.0)10740.2
(7072.4, 13791.2)4602.8
(3021.1, 5851.5)YLD 1137.2
(707.8, 1600.1)691.2
(416.4, 1016.8)446.1
(266.1, 648.4)1146.3
(720.0, 1620.5)551.5
(658.0, 1468.2)594.8
(358.6, 874.6)DALY 12105.0
(7980.2, 15626.1)8181.0
(5398.3, 10560.3)3924.0
(2579.2, 5080.3)16489.3
(10902.8, 21228.8)11291.7
(7413.5, 14552.3)5197.6
(3418.4, 6725.8)YLL
Rate1.48
(0.98, 1.89)1.98
(1.30, 2.51)0.97
(0.63, 1.22)1.85
(1.22, 2.35)2.56
(1.69, 3.29)1.12
(0.74, 1.42)YLD
Rate0.15
(0.10, 0.22)0.18
(0.11, 0.27)0.12
(0.07, 0.18)0.14
(0.09, 0.20)0.13
(0.16, 0.35)0.15
(0.09, 0.21)DALY
Rate1.63
(1.08, 2.11)2.17
(1.42, 2.78)1.08
(0.71, 1.40)1.99
(1.31, 2.56)2.70
(1.77, 3.47)1.26
(0.83, 1.64)
doi: 10.3967/bes2017.096
Temporal Trend in Lung Cancer Burden Attributed to Ambient Fine Particulate Matter in Guangzhou, China
-
Abstract:
Objective To estimate the lung cancer burden that may be attributable to ambient fine particulate matter (PM2.5) pollution in Guangzhou city in China from 2005 to 2013. Methods The data regarding PM2.5 exposure were obtained from the 'Ambient air pollution exposure estimation for the Global Burden of Disease 2013' dataset at 0.1°×0.1° spatial resolution. Disability-adjusted life years (DALYs) were estimated based on the information of mortality and incidence of lung cancer. Comparative risk analysis and integrated exposure-response function were used to estimate attributed disease burden. Results The population-weighted average concentration of PM2.5 was increased by 34.6% between 1990 and 2013, from 38.37 μg/m3 to 51.31 μg/m3. The lung cancer DALYs in both men and women were increased by 36.2% from 2005 to 2013. The PM2.5 attributed lung cancer DALYs increased from 12105.0 (8181.0 for males and 3924.0 for females) in 2005 to 16489.3 (11291.7 for males and 5197.6 for females) in 2013. An average of 23.1% lung cancer burden was attributable to PM2.5 pollution in 2013. Conclusion PM2.5 has caused serious but under-appreciated public health burden in Guangzhou and the trend deteriorates. Effective strategies are needed to tackle this major public health problem. -
Table 1. Age-, Sex-specific Incidence Rate (Per 100, 000) of Lung Cancer in 2005 and 2013 in Guangzhou, China
Age 2005 2013 Total Male Female Total Male Female 0- 0.28 0.10 0.47 0.06 0.11 0.00 20- 0.56 0.46 0.67 0.69 0.81 0.57 30- 1.11 1.46 0.75 4.11 3.48 4.72 40- 3.69 4.38 2.94 21.16 27.11 15.17 50- 10.93 13.92 7.93 72.83 95.31 49.77 60- 38.04 48.88 27.24 168.58 237.51 102.91 70- 104.06 148.63 64.94 303.94 433.71 189.10 80- 506.97 902.19 281.52 349.95 512.74 237.83 Total 52.07 66.26 37.14 52.54 68.29 36.49 Table 2. Age-, Sex-specific Mortality Rate (Per 100, 000) of Lung Cancer in 2005 and 2013 in Guangzhou, China
Age 2005 2013 Total Male Female Total Male Female 0- 0.00 0.00 0.00 0.06 0.11 0.00 20- 0.20 0.30 0.08 0.41 0.40 0.42 30- 0.53 0.98 0.08 2.32 2.27 2.36 40- 2.40 2.23 2.59 15.04 19.65 10.40 50- 6.27 7.91 4.64 54.34 78.27 29.79 60- 24.99 35.13 14.88 121.61 181.93 64.15 70- 66.16 103.06 33.78 268.43 401.98 150.25 80- 339.46 645.54 164.85 373.03 536.99 260.10 Total 33.03 43.38 22.18 43.47 58.88 27.76 Table 3. Years of Life Lost (YLL), Years Lived with Disability (YLD), Disability-adjusted Life Years (DALYs) and the Corresponding Rates (per 1, 000) with 95% Uncertainty Interval for Lung Cancer in 2005 and 2013 in Guangzhou, China
Item 2005 2013 Total Male Female Total Male Female YLL 47527.0
(46491.7, 48507.1)32456.0
(31560.6, 33282.8)15071.0
(14670.7, 15474.9)66486.1
(65057.2, 67892.8)46540.8
(45272.9, 47791.3)19945.4
(19419.2, 204458)YLD 4928.0
(3939.6, 5975.1)2995.0
(2229.1, 3847.3)1933.0
(1424.9, 2453.4)4967.4
(4020.3, 6048.5)2389.8
(1779.4, 3069.1)2577.6
(1920.3, 3309.4)DALY 52455.0
(50888.4, 54047.3)35451.0
(34004.2, 36919.3)17004.0
(16191.1, 17799.1)71453.5
(69679.2, 73226.3)48930.6
(47289.5, 50533.3)22522.9
(21470.6, 23557.8)YLL
Rate6.42
(6.28, 6.55)8.60
(8.32, 8.78)4.20
(4.06, 4.28)8.01
(7.84, 8.18)11.11
(10.81, 11.41)4.85
(4.72, 4.97)YLD
Rate0.67
(0.53, 0.81)0.80
(0.59, 1.01)0.50
(0.39, 0.68)0.60
(0.48, 0.73)0.57
(0.42, 0.73)0.63
(0.47, 0.81)DALY
Rate7.08
(6.87, 7.30)9.40
(8.97, 9.74)4.70
(4.48, 4.92)8.61
(8.40, 8.82)11.68
(11.29, 12.07)5.48
(5.22, 5.73)Table 4. Years of Life Lost (YLL), Years Lived With Disability (YLD), and Disability-adjusted Life Years (DALYs) with 95% Uncertainty Intervals for Lung Cancer Attributed to PM2.5 in 2013 in Guangzhou, China
Item 2005 2013 Total Male Female Total Male Female YLL 10967.8
(7229.5, 13964.7)7489.8
(4910.3, 9519.8)3477.9
(2282.6, 4425.9)15342.9
(10116.6, 19542.0)10740.2
(7072.4, 13791.2)4602.8
(3021.1, 5851.5)YLD 1137.2
(707.8, 1600.1)691.2
(416.4, 1016.8)446.1
(266.1, 648.4)1146.3
(720.0, 1620.5)551.5
(658.0, 1468.2)594.8
(358.6, 874.6)DALY 12105.0
(7980.2, 15626.1)8181.0
(5398.3, 10560.3)3924.0
(2579.2, 5080.3)16489.3
(10902.8, 21228.8)11291.7
(7413.5, 14552.3)5197.6
(3418.4, 6725.8)YLL
Rate1.48
(0.98, 1.89)1.98
(1.30, 2.51)0.97
(0.63, 1.22)1.85
(1.22, 2.35)2.56
(1.69, 3.29)1.12
(0.74, 1.42)YLD
Rate0.15
(0.10, 0.22)0.18
(0.11, 0.27)0.12
(0.07, 0.18)0.14
(0.09, 0.20)0.13
(0.16, 0.35)0.15
(0.09, 0.21)DALY
Rate1.63
(1.08, 2.11)2.17
(1.42, 2.78)1.08
(0.71, 1.40)1.99
(1.31, 2.56)2.70
(1.77, 3.47)1.26
(0.83, 1.64) -
[1] Pope CR, Burnett RT, Thun MJ, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA, 2002; 287, 1132-41. doi: 10.1001/jama.287.9.1132 [2] Lepeule J, Laden F, Dockery D, et al. Chronic exposure to fine particles and mortality:an extended follow-up of the Harvard Six Cities study from 1974 to 2009. Environ Health Perspect, 2012; 120, 965-70. doi: 10.1289/ehp.1104660 [3] Hales S, Blakely T, Woodward A. Air pollution and mortality in New Zealand:cohort study. J Epidemiol Community Health, 2012; 66, 468-73. doi: 10.1136/jech.2010.112490 [4] Pope CR, Burnett RT, Turner MC, et al. Lung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke:shape of the exposure-response relationships. Environ Health Perspect, 2011; 119, 1616-21. doi: 10.1289/ehp.1103639 [5] Greenwell LL, Moreno T, Jones TP, et al. Particle-induced oxidative damage is ameliorated by pulmonary antioxidants. Free Radic Biol Med, 2002; 32, 898-905. doi: 10.1016/S0891-5849(02)00782-7 [6] International Agency for Research on Cancer. Available from http://monographs.iarc.fr/ENG/Classification/latest_classif.php. [2017-05-12]. [7] Raaschou-Nielsen O, Andersen ZJ, Beelen R, et al. Air pollution and lung cancer incidence in 17 European cohorts:prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). The Lancet Oncology, 14, 813-22. doi: 10.1016/S1470-2045(13)70279-1 [8] Brauer M, Freedman G, Frostad J, et al. Ambient Air Pollution Exposure Estimation for the Global Burden of Disease 2013. Environ Sci Technol, 2016; 50, 79-88. doi: 10.1021/acs.est.5b03709 [9] Fang D, Wang Q, Li H, et al. Mortality effects assessment of ambient PM2.5 pollution in the 74 leading cities of China. Sci Total Environ, 2016; 56-570, 1545-52. http://pubmed.cn/27395080 [10] WHO Regional Office for Europe. Air quality guidelines. Global update 2005. Particulate matter, ozone, nitrogen dioxide and sulfur dioxide. Copenhagen: World Health Organization, 2006. [11] Ministry of Environmental Protection of the People's Republic of China. http://kjs.mep.gov.cn/hjbhbz/bzwb/dqhjbh/dqhjzlbz/201203/t20120302_224165.shtml. [2017-12-20] [12] Ministry of Environmental Protection of the People's Republic of China. http://www.zhb.gov.cn/hjzl/zghjzkgb/gshjzkgb/[2016-12-20] [13] Kan H, Chen B. A case-crossover analysis of air pollution and daily mortality in Shanghai. J Occup Health, 2003; 45, 119-24. doi: 10.1539/joh.45.119 [14] Zhang P, Dong G, Sun B, et al. Long-term exposure to ambient air pollution and mortality due to cardiovascular disease and cerebrovascular disease in Shenyang, China. PLoS One, 2011; 6, e20827. doi: 10.1371/journal.pone.0020827 [15] Guo Y, Zeng H, Zheng R, et al. The burden of lung cancer mortality attributable to fine particles in China. Sci Total Environ, 2017; 1460-6. [16] Liu J, Han Y, Tang X, et al. Estimating adult mortality attributable to PM2.5 exposure in China with assimilated PM2.5 concentrations based on a ground monitoring network. Sci Total Environ, 2016, 568; 1253-62. doi: 10.1016/j.scitotenv.2016.05.165 [17] Song C, He J, Wu L, et al. Health burden attributable to ambient PM2.5 in China. Environ Pollut, 2017; 223, 575-86. doi: 10.1016/j.envpol.2017.01.060 [18] Feng J, Yu H, Liu S, et al. PM2. 5 levels, chemical composition and health risk assessment in Xinxiang, a seriously air-polluted city in North China. Environ Geochem Health. 2016 Sep 9. [Epub ahead of print] [19] Li P, Xin J, Wang Y, Li G, et al. Association between particulate matter and its chemical constituents of urban air pollution and daily mortality or morbidity in Beijing City. Environ Sci Pollut Res Int, 2015; 22, 358-68. doi: 10.1007/s11356-014-3301-1 [20] Zhang YS, Ma GX, Yu F, et al. Health damage assessment due to PM2.5 exposure during haze pollution events in Beijing-Tianjin-Hebei region in January 2013. Natl Med J China. 2013; 93, 2707-10. (In Chinese) [21] Guan WJ, Zheng XY, Chung KF, et al. Impact of air pollution on the burden of chronic respiratory diseases in China:time for urgent action. Lancet, 2016; 388, 1939-51. doi: 10.1016/S0140-6736(16)31597-5 [22] Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990-2010:findings from the Global Burden of Disease Study 2010. Lancet, 2013; 381, 1987-2015. doi: 10.1016/S0140-6736(13)61097-1 [23] Gridded Population of the World (GPW), v3|SEDAC. http://sedac.ciesin.columbia.edu/data/collection/gpw-v3. [2017-04-16] [24] Murray CJ. Quantifying the burden of disease:the technical basis for disability-adjusted life years. Bull World Health Organ, 1994; 72, 429-45. http://www.who.int/iris/handle/10665/52181 [25] Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010:a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012; 380, 2197-223. doi: 10.1016/S0140-6736(12)61689-4 [26] Salomon JA, Haagsma JA, Davis A, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health, 2015; 3, e712-23. doi: 10.1016/S2214-109X(15)00069-8 [27] Barendregt JJ, Oortmarssen GJ van, Vos T, et al. A generic model for the assessment of disease epidemiology:the computational basis of DisMod Ⅱ. Population Health Metrics, 2003; 1, 4. doi: 10.1186/1478-7954-1-4 [28] Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010:a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012; 380, 2224-60. doi: 10.1016/S0140-6736(12)61766-8 [29] Murray CJ, Ezzati M, Lopez AD, et al. Comparative quantification of health risks:Conceptual framework and methodological issues. Popul Health Metr, 2003; 14, 1. http://www.oalib.com/paper/272148 [30] Burnett RT, Pope CR, Ezzati M, et al. An integrated risk function for estimating the global burden of disease attributable to ambient fine particulate matter exposure. Environ Health Perspect, 2014; 122, 397-403. https://www.ncbi.nlm.nih.gov/pubmed/?term=An+integrated+risk+function+for+estimating+the+global+burden+of+disease+attributable+to+ambient+fine+particulate+matter+exposure. [31] Mathers CD, Salomon JA, Ezzati M, et al. Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates. Global Burden of Disease and Risk Factors. Washington (DC): World Bank; 2006. [32] Zhang L, Chen R, Lv J. Spatial and seasonal variations of polycyclic aeromatic hydrocarbons (PAHs) in ambient particulate matter (PM10, PM2.5) in three mega-cities in China and identification of major contributing source types. Bull Environ Contam Toxicol, 2016; 96, 827-32. doi: 10.1007/s00128-016-1810-y [33] Zhu H, Zhao S. Comparation of main atmospheric pollutants level and distribution in typical cities of China. Ecology and Environment Sciences, 2014; 23, 791-6. (In Chinese) [34] US. Energy Information Administration. Available at: https://www.eia.gov/beta/international/?fips=ch.[201-709-12] [35] Wei Jie Seow, Wei Hu, Roel Vermeulen, et al. Household air pollution and lung cancer in China:a review of studies in Xuanwei. Chinese Journal of Cancer, 2014; 33, 471-5. (In Chinese) http://www.cnki.com.cn/Article/CJFDTotal-AIZH201410002.htm [36] Kristin Aunan, Shuxiao Wang. Internal migration and urbanization in China:Impacts on population exposure to household air pollution (2000-2010). Science of the Total Environment, 2014; 481, 186-95. doi: 10.1016/j.scitotenv.2014.02.073 [37] Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013:a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2015; 386, 743-800. doi: 10.1016/S0140-6736(15)60692-4 [38] GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013:a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2015; 385, 117-71. doi: 10.1016/S0140-6736(14)61682-2 [39] Murray CJ, Barber RM, Foreman KJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013:quantifying the epidemiological transition. Lancet, 2015; 386, 2145-91. doi: 10.1016/S0140-6736(15)61340-X [40] GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015:a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 2016; 388, 1659-724. doi: 10.1016/S0140-6736(16)31679-8 [41] GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015:a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 2016; 388, 1603-58. doi: 10.1016/S0140-6736(16)31460-X [42] Global Burden of Disease Study 2013. Global Burden of Disease Study 2013 (GBD 2013) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2015. [43] Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990-2013:a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet, 2016; 387, 251-72. doi: 10.1016/S0140-6736(15)00551-6 [44] Li S, Meng L, Chiolero A, et al. Trends in smoking prevalence and attributable mortality in China, 1991-2011. Prev Med, 2016; 93, 82-7. doi: 10.1016/j.ypmed.2016.09.027 [45] Yang WS, Zhao H, Wang X, et al. An evidence-based assessment for the association between long-term exposure to outdoor air pollution and the risk of lung cancer. Eur J Cancer Prev, 2016; 25, 163-72. doi: 10.1097/CEJ.0000000000000158 [46] Krewski D, Jerrett M, Burnett RT, et al. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality. Res Rep Health Eff Inst, 2009; 140, 115-36. https://cfpub.epa.gov/ncer_abstracts/index.cfm/fuseaction/display.abstractDetail/abstract/10156/report/0 [47] Norman R, Cairncross E, Witi J, et al. Estimating the burden of disease attributable to urban outdoor air pollution in South Africa in 2000. S Afr Med J, 2007; 97, 782-90. [48] Ginsberg GM, Kaliner E, Grotto I. Mortality, hospital days and expenditures attributable to ambient air pollution from particulate matter in Israel. Isr J Health Policy Res, 2016; 5, E-Collection 2016. [49] Fu J, Jiang D, Lin G, et al. An ecological analysis of PM2.5 concentrations and lung cancer mortality rates in China. BMJ Open, 2015; 5, e0094. doi: 10.1007/s10404-014-1499-3